In B-cell chronic lymphocytic leukemia (B-CLL), soluble APRIL stimulates NF- μB activation, and protects B-CLL cells from spontaneous or drug-induced apoptosis [21]. This evidence concerns the gene TNFSF13 and B-cell chronic lymphocytic leukemia.